USPTO serial 79416541
GRIFOLS.
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 3, 2026
- Examiner
- MOULTON, NICHOLAS C
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GRIFOLS.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ashly I. Boesche
Ashly I. Boesche Pattishall, McAuliffe, Newbury, Hilliard125 South Wacker Drive, Suite 2050Chicago, IL 60606United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for industry and science, namely, chemicals for use in industry and science; blood culture media for scientific use; chemical substances for use in the prevention of the coagulation of albumin in blood for industrial and scientific purposes; biological preparations for industry and science | ACTIVE | — |
| 005 | Pharmaceutical products, namely, preparations and substances for medical use; hygienic and sanitary products for medical use in the treatment of blood disorders; pharmaceutical products, in particular parenteral solutions for medical use sold in polypropylene containers; pharmaceutical, biological and diagnostic preparations for medical use, in particular, protein preparations derived from plasma for medical use; pharmaceutical preparations for use in the treatment of blood conditions; blood plasma and components thereof, namely, antibodies, albumin, and coagulation factors for the treatment of pulmonary diseases, hemophilia and coagulation disorders, infections, shock, blood loss due to trauma, burns and surgery, immune disorders, hepatitis, tetanus and exposure to rabies; reagents for clinical analyses for medical use; diagnostic reagents for medical use | ACTIVE | — |
| 009 | Scientific, research apparatus and instruments, namely, nucleic acid amplification apparatus for laboratory use, diagnostic biomolecule and DNA sequence detection devices for scientific research purposes, laboratory instrument for the analysis of proteins and proteomes in a biological sample for research use, and spectrophotometers for laboratory use; sound, image or data recording, transmission, reproduction or processing apparatus and instruments, namely, computer hardware for data processing; computer programs and software, recorded and downloadable, for analyzing blood plasma for medical and scientific research purposes; downloadable electronic publications in the nature of books, hand-outs, workbooks, and newsletters in the field of pharmaceuticals, blood plasma products for medical purposes, medical research, medical devices and medicine; downloadable computer software for performing remote medical and scientific diagnostic; filters for blood and blood components for laboratory experiments; plasma display panel apparatus; downloadable computer programs for the collection of blood and blood plasma products; downloadable computer programs for the collection and storage of information relating to blood plasma donors and donated plasma; downloadable computer programs for operating blood and blood plasma processing equipment | ACTIVE | — |
| 010 | Surgical and medical apparatus and instruments for use in in blood testing; suture materials; Apparatus and instruments for blood analysis, microtiter plates to determine the blood group, microtiter plates containing reagents to determine the blood group for medical purposes; automated blood collection apparatus in the nature of bags and tubes; automated instruments for blood separation for medical purposes; roller mixers for blood samples; blood collection tubes for medical use; blood glucose monitoring apparatus for medical purposes; apparatus for blood tests for medical use; blood collection bags for medical use; medical diagnostic instruments for testing blood namely, diagnostic micro test plates for medical use; medical apparatus and instruments, in particular medical apparatus and instruments for the treatment of Alzheimer's and cognitive disorders | ACTIVE | — |
| 035 | Provision of online marketplaces for buyers and sellers of goods and services; procurement services, namely, purchasing of goods and services in the field of pharmaceuticals, and medical diagnostic reagents and medical diagnostic testing equipment for third parties; retail and wholesale store services and retail and wholesale store services via global computer networks for pharmaceutical products, preparations for medical use, biological preparations for medical purposes, blood plasma, reagents for clinical analysis for medical use; customer loyalty services for commercial, promotional or advertising purposes; compilation of information in computer databases; compilation of statistics; management of computerized files; distribution of samples for publicity purposes; document reproduction in the nature of photocopying services | ACTIVE | — |
| 040 | Custom manufacture of pharmaceutical products, in particular sterilized solutions, lipidic emulsions, sanitary products and plastic components | ACTIVE | — |
| 041 | Educational services, namely, conducting classes, seminars, conferences, workshops in the fields of pharmaceuticals, blood plasma products for medical purposes, medical research, medical devices and medicine and distribution of training materials in connection therewith; educational services, namely, providing training of teachers, engineers, for certification in the fields of pharmaceuticals, blood plasma products for medical purposes, medical research, medical devices and medicine; entertainment services in the nature of production of motion pictures, television shows, multimedia entertainment content; Event management services being organization and hosting of educational events in the field of pharmaceuticals, blood plasma products for medical purposes, medical research, medical devices and medicine; services for organization and hosting of congresses, conferences, meetings or seminars in the field of pharmaceuticals, blood plasma products for medical purposes, medical research, medical devices and medicine; providing information about education in the medical field, medical research field, and pharmaceutical field; conducting of events for entertainment and education purposes in the fields of pharmaceuticals, blood plasma products for medical purposes, medical research, medical devices and medicine; organization of exhibitions for recreational, cultural or educational purposes; provision of education, in particular, developing, organizing and conducting programs for instruction on all processes for the cultivation, analysis and control of plasma, production processes of plasma derivatives and bioethics, economics, regulations, compliance and quality control related thereto | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design services in the field of pharmacology, pharmaceuticals, and biochemistry; development of pharmaceutical products, in particular sterilized solutions, lipidic emulsions, sanitary products and plastic components; blood testing services for scientific research; scientific research in the nature of conducting clinical trials for others; providing temporary use of online non-downloadable computer programs for tracking, collecting and storing information related to blood plasma donors and donated plasma; design and development of diagnostic apparatus; biological research; rental of software for analyzing blood plasma for medical and scientific research purposes; electronic data storage; computer software installation and maintenance; quality control of goods and services; research and development of new products for others; scientific laboratory services; conducting technical research projects in the field of pharmaceutical studies; technological consultancy services in the technology field of computer hardware and computer software | ACTIVE | — |
| 044 | Medical services; medical services relating to the removal, treatment and processing of human blood; blood bank services; collection and preservation of blood banks; providing information relating to blood donation; medical laboratory services for the analysis of blood samples for diagnostic treatment purposes; medical diagnostic services; medical clinic services; hospital services; medical assistance; rental of medical equipment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MARCA GRIFOLS, S.L.
- Other trademarks owned by MARCA GRIFOLS, S.L.
- Other trademarks owned by MARCA GRIFOLS, S.L.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GRIFOLS.
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 28, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 28, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 23, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 7, 2026 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jul 6, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 5, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 16, 2026 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jun 15, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 3, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 16, 2026 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Mar 16, 2026 | CHPN | POST PUBLICATION AMENDMENT – NOT ENTERED | — |
| Mar 11, 2026 | APET | ASSIGNED TO PETITION STAFF | — |
| Mar 3, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 3, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 13, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jan 13, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 13, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 7, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 12, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 9, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 9, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 9, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 9, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 25, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 25, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 25, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 25, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 25, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 25, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 25, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 19, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 3, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 3, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 28, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 27, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 19, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 8, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 8, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 6, 2025 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |